Potenza Therapeutics' Series A - II Round

Potenza Therapeutics raised a round of funding on December 29, 2017.

Potenza Therapeutics is a preclinical stage biotechnology company that is focused on cancer immunotherapy. Potenza is discovering and developing therapeutics that stimulate a patients immune system to…

Articles about Potenza Therapeutics' Series A - II Round: